Page last updated: 2024-11-06

prednisolone and Keratoconjunctivitis Sicca

prednisolone has been researched along with Keratoconjunctivitis Sicca in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Keratoconjunctivitis Sicca: Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, HK1
Ryu, IH1
Seo, KY1
Hong, S1
Kim, HC1
Kim, EK1
Gran, JT1

Trials

1 trial available for prednisolone and Keratoconjunctivitis Sicca

ArticleYear
Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Ophthalmology, 2006, Volume: 113, Issue:2

    Topics: Administration, Topical; Adult; Aged; Conjunctiva; Double-Blind Method; Enzyme-Linked Immunosorbent

2006

Other Studies

1 other study available for prednisolone and Keratoconjunctivitis Sicca

ArticleYear
Multiorgan sarcoidosis presenting with symmetric polyarthralgia, cutaneous vasculitis, and sicca symptoms.
    Scandinavian journal of rheumatology, 1997, Volume: 26, Issue:3

    Topics: Anti-Inflammatory Agents; Arthralgia; Humans; Keratoconjunctivitis Sicca; Male; Middle Aged; Prednis

1997